{
  "ticker": "TSLA",
  "target_date": "2025-06-16",
  "actual_date": "2025-06-16",
  "collected_at": "2025-12-08T11:53:55.729494",
  "price": {
    "open": 331.29,
    "high": 332.05,
    "low": 326.41,
    "close": 329.1300048828125,
    "volume": 83925900,
    "change_1d_pct": 1.17,
    "change_7d_pct": 15.61,
    "change_30d_pct": 14.6
  },
  "technicals": {
    "rsi_14": 38.24,
    "sma_20": 332.95,
    "sma_50": 298.33,
    "macd": 4.131,
    "macd_signal": 7.498,
    "macd_histogram": -3.366,
    "bb_upper": 372.8,
    "bb_lower": 293.11,
    "price_vs_sma20_pct": -1.15,
    "price_vs_sma50_pct": 10.33,
    "volume_ratio": 0.7
  },
  "fundamentals": {
    "market_cap": 1459769180160,
    "pe_ratio": 300.63025,
    "forward_pe": 135.4692,
    "price_to_book": 18.244251,
    "price_to_sales": 15.264283,
    "profit_margin": 5.31,
    "operating_margin": 6.63,
    "roe": 6.79,
    "roa": 2.35,
    "revenue_growth": 11.6,
    "earnings_growth": -37.1,
    "debt_to_equity": 17.082,
    "current_ratio": 2.066,
    "quick_ratio": 1.486,
    "fifty_two_week_high": 488.54,
    "fifty_two_week_low": 214.25,
    "fifty_day_avg": 435.217,
    "two_hundred_day_avg": 342.5899,
    "analyst_target": 393.29367,
    "analyst_recommendation": "hold",
    "num_analysts": 41,
    "sector": "Consumer Cyclical",
    "industry": "Auto Manufacturers",
    "pct_from_52w_high": -10.16,
    "pct_from_52w_low": 104.86
  },
  "macro": {
    "spy": {
      "price": 599.24,
      "change_1d_pct": 0.95,
      "change_7d_pct": 0.59
    },
    "vix": {
      "level": 19.11,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.45
    },
    "dollar_index": {
      "level": 98.0
    },
    "gold": {
      "price": 3396.4
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Tesla (TSLA)\u2019s Strength in AI and Robotics Drives Morgan Stanley\u2019s Bullish Outlook",
      "source": "Yahoo",
      "datetime": 1750116567,
      "summary": "Tesla, Inc. (NASDAQ:TSLA) is one of the 12 AI Stocks Every Investor is Watching. On June 13, Morgan Stanley reiterated the stock as \u201cOverweight,\u201d stating that the stock remains extremely well positioned in \u201cdata, robotics, energy, AI, manufacturing, and supporting infrastructure.\u201d \u201cWhile there are a",
      "url": "https://finnhub.io/api/news?id=bea500ccdd91d1dbd116e9edc70a769bd5168a7d3a5b1930d797565fd39ae42d"
    },
    {
      "headline": "Dow Jones Futures Fall On Trump Iran Comments; Meta, Palantir, Nvidia, Tesla Rally",
      "source": "DowJones",
      "datetime": 1750116385,
      "summary": "Dow Jones Futures Fall On Trump Iran Comments; Meta, Palantir, Nvidia, Tesla Rally",
      "url": "https://finnhub.io/api/news?id=f6dc9b00ceaff1ebca2972dd45da3b72801ed348f5f0372938292d0dc319a988"
    },
    {
      "headline": "Tracking Cliff Asness' AQR Capital Management 13F Portfolio - Q1 2025 Update",
      "source": "SeekingAlpha",
      "datetime": 1750108183,
      "summary": "AQR Capital's Q1'25 portfolio hits $97.07B, with top picks in AAPL, NVDA, & AMZN. Active portfolio adjustments show a quantitative, diversified approach. See more.",
      "url": "https://finnhub.io/api/news?id=51b45bd42e92498ec52abd010edf461044394127b04a8428f9c402a3b43b4ef8"
    },
    {
      "headline": "Herbal Medicine Stock With No Sales Rallies 64,000%",
      "source": "Yahoo",
      "datetime": 1750105818,
      "summary": "(Bloomberg) -- A biotech stock focused on herbal medicine has surged by more than 46,000% so far this year and yet, the company itself has made zero revenue \u2014 much less turned a profit. Most Read from BloombergAs Part of a $45 Billion Push, ICE Prepares for a Vast Expansion of Detention SpaceAs Amer",
      "url": "https://finnhub.io/api/news?id=362d34fd8b45101d56b00b8d01c5a889c0f8964f77ce24e642ca00746c262dca"
    },
    {
      "headline": "These Stocks Moved the Most Today: Sarepta, AMD, Tesla, U.S. Steel, Roku, Sage Therapeutics, and More",
      "source": "Yahoo",
      "datetime": 1750104780,
      "summary": "Sarepta Therapeutics falls sharply after suspending shipments of Elevidys for infusions in non-ambulatory patients because of the death of a second patient from acute liver failure.",
      "url": "https://finnhub.io/api/news?id=2c2f2fb8b98a8d9767bc3b6ed376a3bf503d7ba2252cb9566a9b18d7786576c4"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-06-16",
      "description": "xslF345X05/edgardoc.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/1318605/000197292825000003/xslF345X05/edgardoc.xml"
    },
    {
      "form": "4",
      "date": "2025-06-09",
      "description": "xslF345X05/tm2517471-1_4seq1.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/1318605/000110465925057932/xslF345X05/tm2517471-1_4seq1.xml"
    },
    {
      "form": "4",
      "date": "2025-06-04",
      "description": "xslF345X05/tm2517124-1_4seq1.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/1318605/000110465925056561/xslF345X05/tm2517124-1_4seq1.xml"
    },
    {
      "form": "4",
      "date": "2025-05-29",
      "description": "xslF345X05/tm2516319-2_4seq1.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/1318605/000110465925054372/xslF345X05/tm2516319-2_4seq1.xml"
    },
    {
      "form": "4",
      "date": "2025-05-29",
      "description": "xslF345X05/tm2516319-1_4seq1.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/1318605/000110465925054371/xslF345X05/tm2516319-1_4seq1.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}